News & Media

Stay in the know
News

Joint ncRNA Symposium and Liquid Biopsy Summit 2022

4 October 2022

  N2CR had the privilege of helping to host the Joint NUS ncRNA Symposium and Liquid Biopsy Summit from 20 – ...

Read More →
Research News

Novel therapy for cancers with aberrant STAT3 activation

5 September 2022

Aberrant activation of the transcription factor, STAT3, can promote cancer progression and occurs in various cancer type...

Read More →
Research News

Black cardamom extract kills lung cancer cells

5 September 2022

Black cardamom (A. subulatum), a commonly used spice, is also used in traditional medicine as a component of ayurvedic f...

Read More →
Research News

New drug as potential therapeutic for Asian patients with advanced Cancer

1 June 2022

The drug Selinexor blocks specific protein that has been shown to be overexpressed in many types of cancer. Authors in t...

Read More →
Research News

A new protein as a target for cancer treatment

1 June 2022

Any disruption in RNA processing by RNA binding proteins (RBPs) may lead to cancers. This research article published by ...

Read More →
Research News

Gold nanoparticles – An anticancer strategy for breast cancer patients

1 June 2022

Incidence rate for breast cancer has been increasing in females globally. Immunotherapy has recently emerged as a promis...

Read More →
News

New partnership with NUSMed Clinician Scientist Development Unit (CSDU)

1 June 2022

The NUS Yong Loo Lin School of Medicine Clinician Scientist Development Unit (CSDU) provides guidance and training to de...

Read More →
Research News

A novel therapeutic target for hepatocellular carcinoma (HCC)

27 April 2022

Oncoproteins play essential roles in the development of various human cancers. This study led by A/P Gautam Sethi et al ...

Read More →
Research News

COVID-19 Vaccine less efficient in Immunocompromised patients

27 April 2022

This review, led by Dr Raghav Sundar and Dr Soon Yu Yang, show that covid-19 vaccines provide significantly lower protec...

Read More →